Cargando…
MicroRNA‐539 functions as a tumour suppressor in prostate cancer via the TGF‐β/Smad4 signalling pathway by down‐regulating DLX1
Prostate cancer (PCa) is the second leading cause of cancer‐related death in males, primarily due to its metastatic potential. The present study aims to identify the expression of microRNA‐539 (miR‐539) in PCa and further investigate its functional relevance in PCa progression both in vitro and in v...
Autores principales: | Sun, Baogang, Fan, Yingying, Yang, Aijun, Liang, Lunan, Cao, Jinghe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714137/ https://www.ncbi.nlm.nih.gov/pubmed/31298493 http://dx.doi.org/10.1111/jcmm.14402 |
Ejemplares similares
-
DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling
por: Chan, D W, et al.
Publicado: (2017) -
Smad4 (DPC4)--a potent tumour suppressor?
por: Duff, E. K., et al.
Publicado: (1998) -
MicroRNA-539 inhibits the proliferation and migration of gastric cancer cells by targeting SRY-box 5 gene
por: Ding, Shi, et al.
Publicado: (2019) -
MicroRNA-539 inhibits the progression of Wilms’ Tumor through downregulation of JAG1 and Notch1/3
por: Su, Hailong, et al.
Publicado: (2019) -
Down-regulation of MiR-539 Indicates Poor Prognosis in Patients with Pancreatic Cancer
por: Yu, Haibo, et al.
Publicado: (2019)